Iguana Healthcare Management as of Sept. 30, 2014
Portfolio Holdings for Iguana Healthcare Management
Iguana Healthcare Management holds 62 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 7.5 | $14M | 43k | 330.80 | |
| Gilead Sciences (GILD) | 6.7 | $13M | 118k | 106.45 | |
| Amgen (AMGN) | 6.1 | $11M | 82k | 140.47 | |
| Medtronic | 4.5 | $8.5M | 138k | 61.95 | |
| Abbvie (ABBV) | 3.9 | $7.2M | 125k | 57.76 | |
| Celgene Corporation | 3.8 | $7.1M | 75k | 94.79 | |
| Select Sector Spdr Tr option | 3.4 | $6.4M | 100k | 63.91 | |
| Supernus Pharmaceuticals (SUPN) | 2.8 | $5.2M | 600k | 8.69 | |
| Zimmer Holdings (ZBH) | 2.7 | $5.0M | 50k | 100.56 | |
| Merck & Co (MRK) | 2.5 | $4.7M | 80k | 59.28 | |
| Tornier Nv | 2.2 | $4.2M | 175k | 23.90 | |
| Gw Pharmaceuticals Plc ads | 2.2 | $4.0M | 50k | 80.86 | |
| Aerie Pharmaceuticals | 2.1 | $3.9M | 190k | 20.69 | |
| Mylan | 1.9 | $3.6M | 80k | 45.49 | |
| Regeneron Pharmaceut Cmn Stk cmn | 1.9 | $3.6M | 10k | 360.50 | |
| ISIS Pharmaceuticals | 1.8 | $3.3M | 85k | 38.82 | |
| Ultragenyx Pharmaceutical (RARE) | 1.7 | $3.3M | 58k | 56.61 | |
| United Therapeutics Corp Del Call | 1.7 | $3.2M | 25k | 128.64 | |
| Receptos | 1.7 | $3.1M | 50k | 62.12 | |
| Spectranetics Corporation | 1.6 | $3.1M | 115k | 26.57 | |
| Esperion Therapeutics (ESPR) | 1.6 | $3.1M | 125k | 24.46 | |
| Pfizer Inc option | 1.6 | $3.0M | 100k | 29.57 | |
| EnteroMedics | 1.5 | $2.9M | 2.3M | 1.23 | |
| Sanofi Aventis | 1.5 | $2.8M | 50k | 56.44 | |
| Horizon Pharma | 1.4 | $2.7M | 220k | 12.28 | |
| AVANIR Pharmaceuticals | 1.4 | $2.7M | 225k | 11.92 | |
| Dex (DXCM) | 1.4 | $2.6M | 65k | 40.00 | |
| Wright Medical | 1.4 | $2.6M | 85k | 30.31 | |
| Alkermes (ALKS) | 1.4 | $2.6M | 60k | 42.87 | |
| Tenet Healthcare Corporation (THC) | 1.4 | $2.5M | 43k | 59.39 | |
| Amgen Inc option | 1.3 | $2.5M | 18k | 140.46 | |
| Merck & Co Inc New put | 1.3 | $2.4M | 40k | 59.28 | |
| Puma Biotechnology (PBYI) | 1.3 | $2.4M | 10k | 238.60 | |
| Salix Pharmaceuticals | 1.2 | $2.3M | 15k | 156.27 | |
| Auspex Pharmaceuticals | 1.2 | $2.3M | 90k | 25.67 | |
| Chimerix (CMRX) | 1.1 | $2.1M | 75k | 27.63 | |
| Celldex Therapeutics | 1.0 | $1.9M | 150k | 12.96 | |
| Endologix | 1.0 | $1.9M | 183k | 10.60 | |
| Dyax | 1.0 | $1.9M | 185k | 10.12 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $1.8M | 25k | 72.16 | |
| Allergan | 0.9 | $1.8M | 10k | 178.20 | |
| La Jolla Pharmaceuticl Com Par | 0.9 | $1.7M | 180k | 9.61 | |
| Novadaq Technologies | 0.8 | $1.6M | 125k | 12.69 | |
| Aratana Therapeutics | 0.8 | $1.5M | 150k | 10.04 | |
| Arrowhead Research | 0.7 | $1.3M | 90k | 14.78 | |
| OraSure Technologies (OSUR) | 0.7 | $1.3M | 175k | 7.22 | |
| Syneron Medical Ltd ord | 0.6 | $1.2M | 120k | 10.02 | |
| Impax Laboratories | 0.6 | $1.2M | 50k | 23.72 | |
| Celldex Therapeutics Inc cmn | 0.5 | $972k | 75k | 12.96 | |
| Flexion Therapeutics | 0.5 | $913k | 50k | 18.26 | |
| Cymabay Therapeutics | 0.5 | $855k | 125k | 6.84 | |
| Sanofi-Aventis SA (SNY) | 0.5 | $846k | 15k | 56.40 | |
| NPS Pharmaceuticals | 0.5 | $845k | 33k | 26.00 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $809k | 10k | 80.90 | |
| Wright Med Group | 0.4 | $758k | 25k | 30.32 | |
| Acceleron Pharma | 0.4 | $756k | 25k | 30.24 | |
| Agios Pharmaceuticals | 0.3 | $614k | 10k | 61.40 | |
| Tornier N V | 0.3 | $598k | 25k | 23.92 | |
| Vanda Pharmaceuticals (VNDA) | 0.3 | $519k | 50k | 10.38 | |
| Assembly Biosciences | 0.2 | $410k | 50k | 8.20 | |
| Egalet | 0.1 | $200k | 35k | 5.71 | |
| Enteromedics | 0.1 | $87k | 70k | 1.24 |
